US clears first ‘living drug’ for tough childhood leukemia – ModernHealthcare.com
|
US clears first 'living drug' for tough childhood leukemia
ModernHealthcare.com The CAR–T cell treatment developed by Novartis Pharmaceuticals and the University of Pennsylvania is the first type of gene therapy to hit the U.S. market — and one in a powerful but expensive wave of custom-made "living drugs" being tested against … |
